Related references
Note: Only part of the references are listed.Keratoacanthomas associated with sorafenib therapy
Heidi H. Kong et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Inflammation of actinic keratoses subsequent to therapy with sorafenib, a multitargeted tyrosine-kinase inhibitor
M. E. Lacouture et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2006)
TGF-β:: a mobile purveyor of immune privilege
Sharon M. Wahl et al.
IMMUNOLOGICAL REVIEWS (2006)
Ultraviolet irradiation induces keratinocyte proliferation and epidermal hyperplasia through the activation of the epidermal growth factor receptor
TB El-Abaseri et al.
CARCINOGENESIS (2006)
RET/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response
E Puxeddu et al.
ENDOCRINE-RELATED CANCER (2005)
Raf kinase as a target for anticancer therapeutics
SS Sridhar et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Ultraviolet radiation and skin cancer: molecular mechanisms
MR Hussein
JOURNAL OF CUTANEOUS PATHOLOGY (2005)
Effects of imatinib on normal hematopoiesis and immune activation
S Appel et al.
STEM CELLS (2005)
Raf-independent deregulation of p38 and JNK mitogen-activated protein kinases are critical for Ras transformation
K Pruitt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Id proteins in cell cycle control and cellular senescence
Z Zebedee et al.
ONCOGENE (2001)
Share Paper
